The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients - Mortazavi-Jahromi, Seyed Shahabeddin; Ahmadzadeh, Arman; Rezaieyazdi, Zahra; Aslani, Mona; Omidian, Saiedeh; Mirshafiey, Abbas (Immunopharmacology and immunotoxicology, 2020)
Keywords: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Cytokines - blood; Female; Hexuronic Acids - therapeutic use; Humans; Interleukin-1 Receptor-Associated Kinases - genetics; Interleukin-6 - blood; Intracellular Signaling Peptides and Proteins - genetics; M2000; Male; MicroRNAs - genetics; Middle Aged; miR-146a; NF-kappa B - genetics; NSAID; rheumatoid arthritis; target molecules (IRAK1; TRAF6; Treatment Outcome; Tumor Necrosis Factor-alpha - blood; Young Adult; β-d-mannuronic acid; β-d-mannuronic acid; NSAID; TRAF6; target molecules (IRAK1; miR-146a; rheumatoid arthritis; M2000